Preparation and evaluation of mafenide acetate liposomal formulation as eschar delivery system

International Journal of Drug Development and Research

Volumn 3, Issue 4, 2011, Pages 129-140

  Makhmalzadeh, Behzad Sharif ^a   Azh, Zahra ^a   Azarpanah, Armita ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug loading; Eschar; Liposome; Mafenide acetate; Permeability

Indexed keywords

LIPOSOME; MAFENIDE ACETATE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; DRUG SYNTHESIS; HYDRATION; LOADING DRUG DOSE; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; PARTICLE SIZE; SUSTAINED DRUG RELEASE;

EID: 84861324381     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Church, D., Elsayed, S., Reid, O., Winston, B., Lindsay, R., 2006. Burn Wound Infections., Clin Micro Rev. (19): 403-434.
2. Tianhong, D., Ying-Ying, H., Sulbha, KS., Javad, TH., Divya, BK., Hamblin, R., 2010. Topical Antimicrobials for Burn Wound Infections. Recent Patents on Anti-Infective Drug Discovery. (28): 124-151.
3. Stefanides, MM., Copeland, CE., Kominos, SD., Yee, RB., 1975. In vitro penetration of topical antiseptics through eschar of burn patent. Ann. Surg. (183): 358-364.
4. El Maghraby, GM., Barry, BW., Williams, AC., 2008. Liposomes and skin: From drug delivery to model membranes. Eur J Pharm Sci. (34): 203-222.
5. Barry, BW., 2002. Drug delivery routes in skin: a novel approach. Adv Drug Del Rev. 54 Suppl. (1):S31-S40.
6. Cevc, G., 2004. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Del Rev. (56): 675-711.
7. Barry, B.W., 2001. Novel mechanisms and devices to enable successful transdermal drug Delivery, Eur J Pharm Sci. (14) 101-114.
8. Tabbakhian, M., Tavakoli, N., Jaafari, MR., Daneshamouz, S., 2006. Enhancement of follicular delivery of finasteride by liposomes and niosomes1. In vitro permeation and in vivo deposition studies using hamster flank and ear models., Int J Pharm. (323): 1-10.
9. Ermer, J.; Performance parameters, calculations and tests.; In: Ermer, J.; Miller, J. H. M.; Method Validation in Pharmaceutical Analysis.; Wiley-VCH, Verlag GMBH.; New York, 2005, pp: 21-119.
10. nd ed. New York: Oxford university press; 2003. p: 3-29.
11. st ed. New York: Oxford university press; 1990. P:37-90.
12. Nii, T., Ishii, F., 2005. Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int. J. Pharm. 298: 198-205.
13. Maestrelli, F., et al. 2006. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes amied for transdermal delivery. Int. J. Pharm. 312: 53-60.
14. Bhatia, A., 2004. Tamoxifen in topical liposomes: development, characterization and in vitro evaluation. J. Pharm. Sci. 7(2): 252-259.
15. Glaves, DM., Goracinova. K.; Fredr-Kambaradz., E. 2002. Release profile of lidocaine HCl from topical liposomal gel formulation. Int. J. Pharm. 242: 381-384.
16. El-Kattan, AF., Maibach, HI., Guy, RH., 2000. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int J Pharm., 2009: 109-119.
17. Ostro, MJ., 1987. Introduction. In: Ostro, M. J. (editor), Liposomes: from Biophysics to therapeutics. Marcel Dekker, New York and Basel.
18. Sharif makhmal zadeh, B., Moghimi, H., Santos, P., Hadgraft, J., Lane, M., 2008. A comparative of the in vitro permeation characteristics of sulphadiazine across synthetic membranes and eschar tissue. Int. Wound. J., 5: 633-638.